investor losses

Law firm seeks investors in $KD securities fraud lawsuit, alleging false statements and inadequate financial controls between August 2024 and February 2026.

Oddity Tech ($ODD) sued for securities violations after concealing algorithm changes that drove up acquisition costs and hurt ad quality.

TruBridge disclosed material accounting errors in 2023-2025 financials, triggering a 10.5% stock decline and spurring shareholder litigation.

Aldeyra Therapeutics stock plunged 71% after FDA rejected its reproxalap dry eye drug, prompting a securities investigation by Rosen Law Firm.

DNOW Inc. stock fell 19.1% following disappointing Q4 2025 results that missed expectations, triggering securities investigation and class action lawsuit.

Class action filed against China Liberal Education Holdings over alleged January 2025 pump-and-dump scheme involving social media fraud, resulting in significant investor losses.

Eos Energy Enterprises ($EOSE) faces securities lawsuit after missing revenue guidance by $35-46M, citing production issues. May 5, 2026 deadline for investor claims.

Barclays faces class action investigation after £600M exposure to collapsed UK mortgage lender emerges, triggering 6.3% stock decline.

CRMT shares plummeted 18.2% after reporting Q1 loss of 69 cents per share versus 15 cents prior year. Securities lawsuit investigation underway.

monday.com sued for securities fraud over false growth projections; stock fell 21% on Feb. 9, 2026. Robbins Geller pursuing class action for defrauded investors.

Bragar Eagel & Squire investigates Arq Inc. ($ARQ) after 49% stock collapse following missed earnings, weak guidance, and unexpected production halt.

FDA rejects Disc Medicine's bitopertin drug, triggering 22% stock decline and securities investigation into potential investor losses.

Power Solutions International faces class action lawsuit alleging false statements about data center demand and manufacturing issues. Stock tumbled 19% and 29% following margin misses.

Vital Farms stock fell 10.8% on February 26 after weak earnings, triggering securities litigation investigation by Rosen Law Firm over alleged disclosure violations.

Robbins LLP files class action against Gartner for allegedly misrepresenting growth projections. Stock fell 21% after company disclosed weaker-than-expected contract value growth.

Robbins LLP filed class action against $CHOW for alleged fraud scheme. Stock crashed 84% on December 10 after market manipulation revealed. Lead plaintiff deadline: May 12, 2026.

Law firm investigates $GDDY after Q4 earnings miss. Stock fell 14% on disappointing bookings, .com domain pricing pressure, and cautious 2026 outlook.

Driven Brands ($DRVN) faces securities lawsuit after stock plummeted 40% following disclosure of material accounting errors and internal control failures spanning 2023-2025.

Apollo Global Management ($APO) stock plunged 15% after revelations of undisclosed business dealings with Jeffrey Epstein, triggering a securities class action lawsuit against CEO Marc Rowan.

Hagens Berman investigates $QURE for misrepresenting FDA interactions on gene therapy AMT-130. Stock crashed 49% after FDA publicly rebuked company's data claims.